Changeflow GovPing Healthcare & Life Sciences CJ Cheiljedang L-Alanine Polynucleotide Patent ...
Routine Notice Added Final

CJ Cheiljedang L-Alanine Polynucleotide Patent Application

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

CJ Cheiljedang Corporation filed patent application US20260109957A1 on December 12, 2023, covering a novel polynucleotide and method for producing L-alanine, published April 23, 2026. The application discloses biotechnological methods for L-alanine production using the novel polynucleotide, with CPC classifications in C12N 9/1096 and related enzyme categories. Inventors include Ju-Yeon Kim, Min-Jung Kim, and Ji Hye Lee.

“The present disclosure relates to a novel polynucleotide and a method for producing L-alanine using same.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 236 changes logged to date.

What changed

This document publishes CJ Cheiljedang Corporation's patent application US20260109957A1, disclosing a novel polynucleotide and associated method for producing L-alanine. The application, filed December 12, 2023, covers biotechnological production methods using the specified polynucleotide under CPC classifications C12N 9/1096, C12N 15/52, and related categories. Patent application publications establish the filing date and disclosed content as prior art; no substantive examination or grant has occurred.

For biotechnology and pharmaceutical companies engaged in amino acid production, this published application establishes CJ Cheiljedang's priority date and disclosed method for L-alanine production. Competitors should review the claims when published in full to assess freedom-to-operate implications for their own L-alanine production processes.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

NOVEL POLYNUCLEOTIDE AND METHOD FOR PRODUCING L-ALANINE USING SAME

Application US20260109957A1 Kind: A1 Apr 23, 2026

Assignee

CJ CHEILJEDANG CORPORATION

Inventors

Ju-Yeon KIM, Min-Jung KIM, Ji Hye LEE

Abstract

The present disclosure relates to a novel polynucleotide and a method for producing L-alanine using same.

CPC Classifications

C12N 9/1096 C12N 15/52 C12N 15/77 C12P 13/06 C12Y 206/01002 C12R 2001/15

Filing Date

2023-12-12

Application No.

19117948

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
December 12th, 2023
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260109957A1

Who this affects

Applies to
Manufacturers Pharmaceutical companies Biotechnology firms
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing Amino acid production
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!